News
![Pair of deals boosts Biogen’s early-stage CNS pipeline](/sites/default/files/styles/x_large/public/default_images/empty.jpg?itok=C-Mgnvzj)
Pair of deals boosts Biogen’s early-stage CNS pipeline
Biogen has signed a brace of collaborations to expand its central nervous system (CNS) pipeline, adding new candidates for Alzheimer’s, multiple sclerosis and other neurological diseases.